Share
243 Posts.
lightbulb Created with Sketch. 130
clock Created with Sketch.
27/07/21
14:17
Share
Originally posted by Paulfool:
↑
Amazing Company to Run the Trials, contract and consult with only the best - no coincidence that South Australia has been choosen to stay away fom VIC/NSW covid issues. The IP Patent and Trademark protection is what will launch this into the big leagues, (hard to fathom that IHL not even in the All Ords as yet, still won't make the cut in September rebalance but that is how real wealth is generated being ahead of the curve. Can't wait for announcement regarding PIND meeting request to formalise Dr Paul's clinical trial protocols for GAD's and then any details on the mysterious 2nd Psychedelics trail. This is a Phase 1 safety only trial being run in 'healthy volunteers' so unsure if any efficacy endpoints can be attached. However the key part of this announcement is that this Phase 1 Data will be used for 3 separate FDA IND requests for each of the IHL675a indications, which if reading correctly will jump straight into Phase 2 or Phase 3 trails to be run in the US using the 505 2 b expediated pathway and existing known data about HCQ and CDB drugs. THIS IS HUGE as skipping the need to run 3 separate Phase 1 again will save 10's of millions and 1 - 2 years of development time. I get annoyed that the market does not seem to appreciate the global business that is being built here, but in time will be able to look back and see how each of the last few announcments have laid the bedrock for amazing future success.
Expand
Couldn't agree more regarding the amount of time/money that will be saved getting to market. This is from the Canary Capital website - I believe these guys have got targets/goals and a quiver full of arrows so to speak. It'll be like shooting fish in a barrel. Still a bargain in my opinion.